Thomas Templeman Insider Profile
4 Followers
Thomas Templeman, SVP, Pharmaceutical Ops at Nuvation Bio, holds ― shares in Nuvation Bio (Ticker: NUVB), holds 188.24K shares in Centessa Pharmaceuticals (Ticker: CNTA), holds 22.72K shares in Medivation (Ticker: MDVN).
Thomas Templeman's Trading History
| CNTACentessa Pharmaceuticals | Apr 04, 2023 | ― | Uninformative Sell | 16.00K | $7.62M | |
| MDVNMedivation | Oct 01, 2015 | ― | Uninformative Buy | ― | $1.84M | |
| NUVBNuvation Bio | ― | SVP, Pharmaceutical Ops | ― | ― |
You May Also Like
Thomas Templeman insider profile FAQ
What is the percentage of profitable transactions made by Thomas Templeman?
The percentage of profitable transactions made by Thomas Templeman is 0%.
What is the average return per transaction made by Thomas Templeman?
The average return per transaction made by Thomas Templeman is -66.70%.
What stocks does Thomas Templeman hold?
Thomas Templeman holds: NUVB, MDVN, CNTA stocks.
What was Thomas Templeman's most profitable transaction?
Thomas Templeman’s most profitable transaction was an Informative Sell of CNTA stock on October 4, 2022. The return on the trade was -47.70%.
What is Thomas Templeman's role in Nuvation Bio?
Thomas Templeman's role in Nuvation Bio is SVP, Pharmaceutical Ops.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
